HK inno-n
Sung Bin Cho, currently working at HK inno-n as the General Manager of K-Cap BD and Marketing, Head of Japan Office. Prior to this, Sung Bin has held various managerial positions in companies such as CJ Japan Co., CJ Corporation, Osteosys, Inc., and CJ CheilJedang. Sung Bin has extensive experience in business development, new drug in-licensing, overseas sales, marketing, and account management. Sung Bin also served in the Korean Army as a Sergeant, gaining experience in managing inventory and distribution. Sung Bin holds an MBA from Thunderbird School of Global Management and a Bachelor's degree in Economics from Sungkyunkwan University.
This person is not in any teams
This person is not in any offices
HK inno-n
Since its establishment in 1984, HK inno.N Corp. has tapped into the belief that its business was also helping chart the nation’s future. This belief has served and continues to serve the company well, as it has grown into one of the leading pharmaceutical firms in the nation. Since its establishment in 1984, HK inno.N has gained competitiveness in the businesses of prescription drugs, active pharmaceutical ingredients, health supplements and beauty products. Drawing on the company’s experience and knowhow in developing novel drugs, HK inno.N succeeded in launching ‘K-CAB’, the 30th novel drug to be developed and registered in Korea, to great acclaim. Building on this success, HK inno.N remains committed to growing into a global bio health company built on outstanding products and technologies that bring us closer to a healthier future.